Silk Road Medical, Inc (SILK) Research

Silk Road Medical, Inc. operates as an American medical device company, focusing on innovative solutions for carotid artery disease. The firm's product portfolio is specifically engineered to support transcarotid artery revascularization (TCAR) procedures. Among its key offerings is the ENROUTE Transcarotid Neuroprotection System, designed to directly access the common carotid artery and initiate a temporary reversal of blood flow. The company also provides the ENROUTE Transcarotid Stent System, a distinctive stent characterized by its self-expanding and self-tapering capabilities. For streamlined initial entry to the common carotid artery, Silk Road Medical offers the ENHANCE Transcarotid Peripheral Access Kit. Additionally, the ENROUTE 0.014 Guidewire plays a crucial role in navigating and crossing target lesions, enabling the precise delivery of other interventional devices. Founded in 2007, Silk Road Medical, Inc. maintains its primary corporate offices in Sunnyvale, California.

Market snapshot

Symbol
SILK
Price
$27.49
Day change
-0.04%
Market cap
$1.1B
P/E ratio
-19.14x
52-week range
6.08-27.51
Sector
Healthcare
Industry
Medical - Devices
Analyst price target
$30.58

Peer companies

  • CinCor Pharma, Inc. (CINC)
  • Cardiovascular Systems, Inc. (CSII)
  • CTI BioPharma Corp. (CTIC)
  • EQRx, Inc. (EQRX)
  • Ethzilla Corp. (ETHZ)
  • Paragon 28, Inc. (FNA)
  • Gracell Biotechnologies Inc. (GRCL)
  • Heska Corporation (HSKA)

Recent insider activity

  • Zurbay Donald — D-Return (12610 shares) on 2024-09-17
  • Zurbay Donald — D-Return (146031 shares) on 2024-09-17
  • Zurbay Donald — D-Return (29206 shares) on 2024-09-17
  • Zurbay Donald — D-Return (8910 shares) on 2024-09-17
  • WEATHERMAN ELIZABETH H — D-Return (35185 shares) on 2024-09-17

Open Silk Road Medical, Inc (SILK) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.